RECRUITING

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose this pragmatic trial to test the effectiveness of an existing, ongoing clinical service, the VA National TeleOncology program (NTO), a multilevel telehealth population health management program. The primary aims are to study the intervention and determine its effectiveness on telehealth engagement, clinical quality, and healthcare cost outcomes across levels of Social Determinants of TeleHealth (SDTH) with the goal of promoting health equity.

Official Title

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

Quick Facts

Study Start:2024-06-18
Study Completion:2027-01-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06559059

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. A Veteran
  2. 2. Aged 18 years or older
  3. 3. Newly diagnosed with lung, prostate, breast, or colon cancer within 3 months of telemedicine visit
  4. 4. Engaged in an oncology visit during the 36-month analysis period at a Veterans Affairs Medical Center (VAMC) location.
  1. 1. Veterans who have not seen any providers in the VA within the past year
  2. 2. Patients previously diagnosed with lung, prostate, breast, or colon cancer
  3. 3. Pregnant patients

Contacts and Locations

Study Contact

Janeth Juarez Padilla
CONTACT
646-501-3588
Janeth.juarezpadilla@nyulangone.org
Navid Dardashti
CONTACT
201-906-7713
Navid.dardashti@nyulangone.org

Principal Investigator

Danil Makarov, MD, MHS
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

VA New York Harbor Healthcare System - Brooklyn
Brooklyn, New York, 11209
United States
VA New York Harbor Healthcare System - St. Albans Community Living Center
Jamaica, New York, 11425
United States
VA New York Harbor Health Care System - Manhattan
New York, New York, 10010
United States
VA New York Harbor Healthcare System - Harlem Community Center
New York, New York, 10027
United States
VA New York Harbor Healthcare System - Staten Island Community Clinic
Staten Island, New York, 10314
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Danil Makarov, MD, MHS, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-06-18
Study Completion Date2027-01-01

Study Record Updates

Study Start Date2024-06-18
Study Completion Date2027-01-01

Terms related to this study

Additional Relevant MeSH Terms

  • Lung Cancer Diagnosis
  • Colorectal Cancer (Diagnosis)
  • Prostate Cancer Diagnosis
  • Breast Cancer Diagnosis